Related Experiment Videos

Molecular genetics of hypertrophic cardiomyopathy

J A Towbin1

  • 1Baylor College of Medicine, Pediatric Cardiology, 1 Baylor Plaza, Room 333E, Houston, TX 77030, USA. jtowbin@bcm.tmc.edu

Current Cardiology Reports
|September 12, 2000
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a heart disorder involving thickened heart muscle. This review discusses the genetic basis of HCM, focusing on sarcomere protein genes responsible for this heterogeneous disease.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant cardiac disorder.
  • It is characterized by interventricular septum and left ventricular wall hypertrophy.
  • Histopathology often reveals myofiber disarray.

Purpose of the Study:

  • To review the genetic basis of hypertrophic cardiomyopathy.
  • To discuss the genes encoding sarcomere proteins implicated in familial HCM.
  • To highlight the genetic and clinical heterogeneity of HCM.

Main Methods:

  • Literature review of genetic studies in hypertrophic cardiomyopathy.
  • Identification and listing of known causative genes for familial HCM.
  • Discussion of sarcomere protein involvement.

Main Results:

  • Nine genes encoding sarcomere proteins have been identified for familial HCM.
  • These genes include beta-myosin heavy chain, alpha-tropomyosin, cardiac troponin T, troponin I, myosin binding protein-C, regulatory myosin light chain, essential myosin light chain, cardiac actin, and titin.
  • HCM is a genetically and clinically heterogeneous disease.

Conclusions:

  • The genetic basis of HCM is primarily linked to mutations in sarcomere protein genes.
  • Understanding these genetic factors is crucial for diagnosing and managing HCM.
  • Further research into the genetic underpinnings of HCM is warranted.

Related Concept Videos